millionaire-obsessed-with-“eternal-youth”-undergoes-$25,000-gene-therapy-not-approved-by-the-fdaMillionaire obsessed with “eternal youth” undergoes $25,000 gene therapy not approved by the FDA
El Diario Avatar

By The newspaper

Dec 27, 2023, 17:49 PM EST

Bryan Johnson, a 46-year-old technology entrepreneur, is making headlines with his radical quest to reverse aging and extend your lifespan.

Through his ambitious Project Blueprint, Johnson is investing approximately $2 million each year in various treatments, the latest of which is an experimental gene therapy on a remote Caribbean island.

Johnson’s latest foray into anti-aging is follistatin therapy, a treatment that involves injecting a protein known to increase muscle mass and reduce inflammation.

Despite not being approved by the FDA and lacking published data from medical trials, Johnson underwent his first round of this therapy in September, Business Insider reveals.

The treatment is offered by biotech startup Minicircle, with support from notable figures such as Peter Thiel and Sam Altman. While the average cost is $25,000 per dose, Minicircle does not charge Johnson, considering his high-profile involvement more valuable than the potential fee.

Bryan Johnson’s Comprehensive Anti-Aging Regimen

Project Blueprint is not just about gene therapy; It’s an extensive regimen that Johnson says has given him the skin of a 28-year-old, the heart of a 37-year-old, and the lung capacity of an 18-year-old.

These bold claims have not been independently verified and spark debate about the legitimacy and ethical implications of such intense personal health projects.

Johnson’s approach includes a strict vegan diet, dozens of daily supplements, and a complete lifestyle overhaul of his previous junk food and late-night habits, all in an effort to “live forever.”

Debate surrounding Johnson’s anti-aging initiatives

Johnson’s extreme investment in anti-aging and longevity has sparked fierce debate among scientists, ethicists and the general public. Questions arise about the effectiveness and safety of such experimental treatments, especially when they lack FDA approval or substantial data from medical trials.

Additionally, his case opens up a broader discussion about the ethics of anti-aging technologies, accessibility, and the implications of potentially significantly extending human lifespan.

While Johnson’s efforts are a personal pursuit, they undoubtedly set a precedent and stimulate conversation about the future of human longevity and the role of technology in healthcare.

In short, Bryan Johnson’s ambitious and expensive journey to reverse his biological age and extend his lifespan is a testament to the lengths some are willing to go in pursuit of longevity.

Through Project Blueprint, Johnson is exploring the cutting edge of anti-aging treatments, from follistatin gene therapy to a comprehensive health and lifestyle regimen.

While their efforts are pioneering and reflect significant personal commitment, they also raise important questions about the science of anti-aging, the potential risks of experimental therapies, and the ethical implications of such efforts.

As Johnson continues his search, scientists await the results and implications of his unprecedented journey into the uncharted territory of extended human life.

Keep reading:
· Millionaire spends more than $2 million in an attempt to make his body “young again”
· This new blood test reveals the age of your organs
· Keep your brain young and healthy with these 3 foods

By Scribe